ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,381.35
0.00%
Dow Jones
39,387.76
0.85%
Gold vs US Dollar
2,357.89
0.47%
Brent Oil
84.225
0.33%
Bitcoin
62,903.15
-0.23%
Pepperstone
Advertisement
Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Europe
  5. EU
  6. UCB SA (UCB)

  7. UCB SA (UCB) News

UCB (UCB)

UCB SA
Date:
Sort by:
 Showing the most relevant articles for your search:EU:UCB
DateTimeSourceHeadlineSymbolCompany
22/03/202406:00GlobeNewswire Inc.UCB Convening Notice to the General Meeting of the Shareholders 2024EU:UCBUCB SA
22/03/202406:00GlobeNewswire Inc.UCB Convocation à l'Assemblée Générale des Actionnaires 2024EU:UCBUCB SA
24/05/202314:25GlobeNewswire Inc.ClearPoint Neuro and UCB Enter License Agreement for Gene Therapy Drug DeliveryEU:UCBUCB SA
24/03/202306:30GlobeNewswire Inc.UCB Convocation à L’ Assemblée Générale des Actionnaires 2023EU:UCBUCB SA
24/03/202306:30GlobeNewswire Inc.UCB Convening Notice to the General Meeting of theShareholders 2023EU:UCBUCB SA
13/12/202221:01GlobeNewswire Inc.Praxis Precision Medicines and UCB Announce Epilepsy Research CollaborationEU:UCBUCB SA
25/03/202206:00GlobeNewswire Inc.UCB SA - CONVOCATION A L’ASSEMBLEE GENERALE DES ACTIONNAIRES 2022EU:UCBUCB SA
25/03/202206:00GlobeNewswire Inc.UCB SA/NV - CONVENING NOTICE TO THE GENERAL MEETING OF SHAREHOLDERS 2022EU:UCBUCB SA
26/03/202106:00GlobeNewswire Inc.UCB SA - convocation à l'assemblée générale ordinaireEU:UCBUCB SA
26/03/202106:00GlobeNewswire Inc.UCB SA/NV - Convening notice annual shareholders meetingEU:UCBUCB SA
27/03/202006:00GlobeNewswire Inc.UCB SA : Convocation à l'assemblée générale des actionnairesEU:UCBUCB SA
27/03/202006:00GlobeNewswire Inc.UCB SA/NV : Convening notice to the general meeting of shareholdersEU:UCBUCB SA
22/03/201906:00GlobeNewswire Inc.UCB SA : Convocation à l'assemblée générale des actionnaires qui se tiendra à Bluepoint BrusselsEU:UCBUCB SA
22/03/201906:00GlobeNewswire Inc.UCB SA/NV: Convening Notice to attend the general meeting of shareholders to be held at Bluepoint BrusselsEU:UCBUCB SA
23/10/201806:00GlobeNewswire Inc.UCB and Biogen Announce Topline Results from a Phase 2b Study of Dapirolizumab Pegol in Systemic Lupus ErythematosusEU:UCBUCB SA
20/04/201812:55Cercle FinanceUCB: met la main sur un antiépileptiqueEU:UCBUCB SA
22/02/201813:42Cercle FinanceUCB: bien orienté après des résultats solidesEU:UCBUCB SA
06/11/201721:01GlobeNewswire Inc.Dermira and UCB Agree to End Collaboration Agreement for CIMZIAEU:UCBUCB SA
14/09/201713:00GlobeNewswire Inc.New CIMZIA® (certolizumab pegol) Findings Presented at European Academy of Dermatology and Venereology (EADV) CongressEU:UCBUCB SA
25/07/201706:00GlobeNewswire Inc.UCB and Dermira Announce U.S. and EU Regulatory Submissions for CIMZIA® (certolizumab pegol) for the treatment of Moderate-t...EU:UCBUCB SA
23/05/201716:57Cercle FinanceUCB: poursuit son repli après le problème d'essai clinique.EU:UCBUCB SA
22/05/201710:07Cercle FinanceUCB: plonge après des problèmes sur son Evenity.EU:UCBUCB SA
19/01/201707:00GlobeNewswire Inc.Final CIMZIA® (certolizumab pegol) Phase 3 Trial Meets Primary Efficacy Endpoint in Patients with Moderate-to-Severe Chronic...EU:UCBUCB SA
11/01/201711:11Cercle FinanceUCB: bien orienté, un analyste en soutien.EU:UCBUCB SA
08/12/201607:00GlobeNewswire Inc.Second CIMZIA® (certolizumab pegol) Phase 3 Trial Meets Co-primary Efficacy Endpoints in Patients with Moderate-to-Severe Ch...EU:UCBUCB SA
15/08/201610:27Cercle FinanceUCB: salué pour une décision de justice aux Etats-Unis.EU:UCBUCB SA
25/04/201613:54Cercle FinanceUCB: hausse de 11% du CA au 1er trimestre.EU:UCBUCB SA
08/03/201613:56Cercle FinanceUCB: miné par une dégradation de broker.EU:UCBUCB SA
08/09/201514:35Cercle FinanceUCB: soutenu par un relèvement de broker.EU:UCBUCB SA
03/09/201508:42Cercle FinanceUCB: en tête du Bel 20 après la cession de Kremers.EU:UCBUCB SA
 Showing the most relevant articles for your search:EU:UCB

Your Recent History

LSE
CHLL
Chill Brands
LSE
POLX
Polarean Imaging
LSE
ITM
Itm Power
LSE
TERN
Tern
LSE
SAR
Sareum
LSE
GKP
Gulf Keystone Petroleum
LSE
AGL
Angle
LSE
PET
Petrel Resources
LSE
TYM
Tertiary Minerals
LSE
CLCO
Cloudcoco
LSE
GDR
Genedrive
LSE
SYME
Supply@me Capital
LSE
GDP
Goldplat
NYSE
SPCE
Virgin Galactic
LSE
PEN
Pennant
LSE
EMG
Man
Delayed Upgrade Clock
    ADVFN Logo

    United Kingdom
    Company
    Business
    Popular
    Get The App

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved